Lonza | LONN - Sales Revenues

Stock Price
517.40
Daily Change
-0.80 -0.15%
Monthly
-5.86%
Yearly
-14.31%
Q1 Forecast
512.24

Lonza reported CHF3.58B in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.59B 10M Sep/2025
Almirall EUR 560.46M 71.95M Jun/2025
AstraZeneca USD 15.19B 733M Sep/2025
BASF EUR 14.33B 1.44B Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
Covestro EUR 3.17B 210M Sep/2025
Demant DKK 6.26B 810M Dec/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
Geberit CHF 878.5M 193.2M Mar/2025
Genmab DKK 5.86B 580M Jun/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GN Store Nord DKK 4.68B 720M Dec/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 4.3B 38M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Sika AG CHF 5.68B 251.9M Jun/2025
Smith & Nephew USD 2.96B 134M Dec/2025
Solvay EUR 1.04B 60M Sep/2025
UCB EUR 3.49B 129M Jun/2025